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Background/aim: The Neuropsychiatric Inventory-Clinician (NPI-C) scale is one of the best-known scales for evaluating the behavioral
and psychological symptoms of dementia. This study aimed to assess the reliability and validity of the Turkish version of the NPI-C scale
in patients with Alzheimer disease (AD).
Materials and methods: The NPI-C scale was administered to 125 patients with AD. For reliability, both Cronbach’s α and interrater
reliability were analyzed. The Behavioral Pathology in Alzheimer’s Disease (BEHAVE-AD) scale was applied for validity and, in
addition, the Mini Mental State Examination (MMSE), Instrumental Activities of Daily Living (IADL) scale, and Disability Assessment
of Dementia (DAD) scale were completed.
Results: The Turkish version of the NPI-C scale showed high internal consistency (Cronbach’s α = 0.75) and mostly good interrater
reliability. Assessments of validity showed that the NPI-C and corresponding BEHAVE-AD domains were found to be significantly
correlated, between 0.925 and 0.195. Moreover, the correlations between NPI-C and MMSE were significant for all domains except the
dysphoria, anxiety, and elation/euphoria domains. When we conducted a correlation analysis of NPI-C with IADL, all domains were
statistically significantly correlated except aggression, anxiety, elation/euphoria, and dysphoria.
Conclusion: The Turkish version of the NPI-C scale was found to be a reliable and valid instrument to assess neuropsychiatric symptoms
in Turkish elderly subjects with AD.
Key words: Alzheimer disease, neuropsychiatric symptoms, Neuropsychiatric Inventory-Clinician

1. Introduction
Alzheimer
disease
(AD)
is
a
progressively
neurodegenerative disease that is characterized by cognitive
and memory impairment, progressive deterioration in the
maintenance of daily living activities, and neuropsychiatric
and behavioral symptoms. Behavioral and psychological
symptoms of dementia (BPSDs) are the most burdensome
symptoms of the disease. These symptoms lower the
quality of life of both patients and their caregivers,
leading to an increase in placement in nursing homes.
BPSDs are associated with generally higher healthcare
costs (1–3). Characterizing and quantifying these
symptoms is especially important for the effectiveness of
pharmacological and nonpharmacological therapies.
There have been many scales developed to measure
the neuropsychiatric symptoms of dementia. These
scales can be classified based on whether they measure
* Correspondence: eylemcankurtaran@yahoo.com

the dimensions, severity, or frequency of BPSDs and
according to the subjects to whom they are applied (patient
or caregiver). The most frequently applied instruments
for measuring BPSDs are the Behavioral Pathology
in Alzheimer’s Disease (BEHAVE-AD) scale (4), the
Behavioral Rating Scale for Dementia of the Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD)
(5), the Cornell Scale for Depression in Dementia (Cornell
SDD) (6), the Geriatric Depression Scale (7), the Cohen–
Mansfield Agitation Inventory (CMAI) (8), and the
Neuropsychiatric Inventory (NPI) (9).
The NPI, which originally included only 10 items, was
originally developed by Cummings et al. for assessing
behavioral changes after head trauma (9). In 1997, an
updated NPI with 2 new criteria was introduced in order to
assess psychopathology in dementia patients (10). Different
versions of the NPI were later developed: Neuropsychiatric
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Inventory-Distress (NPI-D) for measuring caregiver
burden (11), the Neuropsychiatric Inventory-Nursing
Home Version (NPI-NH) for institutionalized dementia
patients (12), and the Neuropsychiatric InventoryQuestionnaire (NPI-Q), a shorter version for use in general
clinical practice (13). The NPI was translated and validated
for use in many different languages and cultures, and it has
thus become the most commonly used assessment tool
for measuring BPSDs in patients with AD (14–17) and
frontotemporal dementia (18).
The assessment of behavioral and psychological
symptoms of dementia could be susceptible to bias,
especially when getting information from caregivers who
are exhausted, depressed, or not educated (19). The cultural
beliefs of caregivers about the elderly is also an obstacle
for differentiating among neuropsychiatric symptoms.
Therefore, the judgement of the clinician based on all data
provided by patients and caregivers could be very valuable
in determining the appropriate symptoms of BPSDs. The
NPI-Clinician (NPI-C), the most recent NPI version,
was developed to overcome these limitations (19). The
clinician’s impressions and neuropsychiatric examination
of the patient, along with the caregiver’s impressions, are
essential for the NPI-C.
In this study, the primary aim was to evaluate the
validity and reliability of the Turkish version of the NPI-C,
and the second aim was assessing the correlation of the
NPI-C with the Disability Scale of Dementia (DAD).
2. Materials and methods
2.1. Participants
We recruited 125 patients, along with their caregivers,
from the Geriatric Psychiatry Unit of the Ankara Oncology
Research and Training Hospital.
The exclusion criteria for the patients were severe
physical disabilities such as paraplegia or hemiplegia,
which could increase caregiver burden. The caregivers had
to be in verbal contact with the patient at least 3 times per
week during the 3 months preceding the study and had
to be over 18 years of age. The exclusion criteria for the
caregivers were illiteracy; psychiatric disorders such as
schizophrenia, psychotic disorders, and dementia; having
a score of 17 or above on the Beck Depression Scale; and
not consenting to the study.
A written consent form was obtained from all caregivers
and from those patients who were able to consent. The
study protocol was approved by the Ethics Committee
of the Ankara Oncology Research and Training Hospital
with approval number 2012-7/3 and date of 03.10.2012.
2.2. Procedures
Patients were all community-dwelling subjects diagnosed
with dementia due to AD according to the National
Institute of Neurological and Communicative Disorders
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and Stroke and the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) criteria. The
diagnostic procedure involved a detailed medical history,
physical and neurological examinations, laboratory testing
and, in most cases, magnetic resonance imaging.
The MMSE was used to measure the cognitive state of
the patients (20). The Global Deterioration Scale (GDS)
(21) was applied to the patients to assess the severity of
their dementia. The Lawton–Brody Instrumental Activities
of Daily Living Scale (Lawton–Brody IADL) (22) and the
DAD (23) were used to evaluate daily activities and patient
disability. In addition to the NPI-C, BEHAVE-AD was also
applied to assess the neuropsychiatric symptoms of AD
patients.
2.2.1. NPI-C
The NPI-C was revised from the original NPI and includes
an additional 78 items, split domains for agitation and
aggression, and an extra domain for ‘abnormal vocalization’.
The most important modification of the NPI-C is the
addition of clinician judgement to rate the severity of
each item. A reliability and validity study of the NPI-C
was published by De Medeiros et al. (19). The validity and
reliability of the NPI-C in different cultural settings, such
as Brazil, have been examined (24), and work concerning
the clinician/caregiver difference in rating BPSDs using
the NPI-C has been recently published (25).
For the validity and reliability study of the Turkish
version of the NPI-C, it was first translated into Turkish
by 2 researchers, then a bilingual Turkish individual who
was unfamiliar with the original questionnaire translated
the Turkish version back into English. The final version of
the NPI-C was compared with the original one. Finally, the
NPI-C was applied to 125 patients and their caregivers.
2.3. Statistical analysis
SPSS was used to conduct statistical analysis. The
sociodemographic and clinical characteristics of the
sample were analyzed by descriptive statistical analysis.
2.3.1. Reliability
For the reliability of the Turkish version of the NPI-C,
Cronbach’s alpha correlation coefficient and interrater
reliability were assessed. An internal consistency of 0.70
was sought for all domains of the NPI-C, as recommended
for Cronbach’s alpha correlation coefficient (26).
For the interrater reliability, all the patient-caregiver
dyads were interviewed by 2 independent raters on the
same day. The intraclass correlations and confidence
intervals (95% confidence intervals) of raters were
analyzed.
2.3.2. Validity
The convergent validity of the NPI-C was analyzed by
calculating Pearson’s correlations of NPI-C domains with
BEHAVE-AD. For divergent validity, the correlations of
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NPI-C with MMSE, DAD, Katz ADL, and Lawton IADL
were analyzed. P < 0.05 was adapted as the criterion for
significance.
3. Results
3.1. Sociodemographic and clinical patient characteristics
The patients in the study were mostly female (71.2%, n = 89)
and widowed (54.4%), with a mean age of 76.4 ± 1.2 (min–
max = 62–101) years. The median estimated duration of
AD among patients was 36 (min–max = 12–240) months.
According to the GDS, most of the patients were at stage 4
(45.6%) and 5 (27.2%) of AD. The sociodemographic and
clinical features of the patients are shown in Table 1.
The mean scores and standard deviations of the MMSE
and IADL scales of patients were 16.6 ± 6.4 and 4.5 ± 4.1,
respectively. The median scores and min–max scores of
the DAD and BEHAVE-AD scales were 31 (0–51) and 6
(0–43), respectively.
3.2. Sociodemographic characteristics of the caregivers
The mean age of the caregivers was 49.7 ± 1.1 years.
Caregivers were mostly married (76%) women (66.4%),
Table 1. The sociodemographic and clinical characteristics of
patients diagnosed with AD.
Variables

Patients (n = 125)

Age, years, mean ± SD (range)

76.4 ± 1.2 (62–101)

Sex, n (%)

with a large percentage who were the daughters of patients
(37.6%); 74.4% of caregivers were living with their patient.
The median caregiving duration per day was 3 h, and the
median caregiving duration per month was 24 days (Table 2).
3.3. Internal consistency reliability
The internal consistency of the NPI-C was high, with a
Cronbach’s alpha of 0.75.
3.4. Interrater reliability
The interrater reliability of NPI-C domains were between
0.99 and 0.31 (Table 3). The apathy/indifference and
disinhibition domains had the highest scores of interrater
reliability, with 0.99. Because aggression and elation/
euphoria symptoms did not appear in the 30 patients that
were examined by 2 raters, these domains are not included
in Table 3.
3.5. Convergent validity
Table 4 presents the correlation coefficients for the
NPI-C with the corresponding subscales and questions
of BEHAVE-AD and the entire BEHAVE-AD. The
correlation coefficients of NPI-C with BEHAVE-AD were
also analyzed according to the stages of the GDS (Table 5).
Table 2. Caregivers’ sociodemographic characteristics.
Variables

Caregivers (n = 125)

Age, years, mean ± SD (range)

49.7 ± 1.1 (26–79)

Sex, n (%)

Male

36 (28.8%)

Male

40 (32.6%)

Female

89 (71.2%)

Female

83 (66.4%)

Education, n (%)

Relationship to patient, n (%)

Illiterate

56 (44.8%)

Primary/secondary school

97 (63.2%)

High school

4 (3.2%)

University

4 (3.2%)

Marital status, n (%)

Daughter

47 (37.6%)

Son

32 (25.6%)

Spouse

14 (11.2%)

Daughter-in-law/son-in-law

21 (16.8%)
8 (6.4%)

Married

49 (39.2%)

Other

Widowed/divorced

68 (54.4%)

Residence

Estimated duration of illness
Months, median (range)

36 (12–240)

GDS, n (%)
Stage 4

57 (45.6%)

Stage 5

34 (27.2%)

Stage 6

24 (19.2%)

Stage 7

7 (5.6%)

SD = Standard deviation, GDS = Global Deterioration Scale.

Home

93 (74.4%)

Elderly residence

30 (24%)

Total caregiving days per month
Median (range)

24 days (1–364)

Duration of daily caregiving, in hours
Median (range)

3 h/day (1–24)

SD = Standard deviation.
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Table 3. Interrater reliability with 95% confidence limits for NPI-C domains.
Domain

ICC (95% CI)

Delusions

0.83 (0.634–0.917)

Hallucinations

0.85 (0.685–0.929)

Agitation

0.97 (0.928–0.984)

Dysphoria

0.97 (0.929–0.984)

Anxiety

0.98 (0.958–0.990)

Apathy/Indifference

0.99 (0.979–0.995)

Disinhibition

0.99 (0.976–0.995)

Irritability/Lability

0.94 (0.876–0.972)

Aberrant motor behavior

0.31 (–0.460 to 0.669)

Sleep disorders

0.85 (0.689–0.930)

Appetite and eating disorders

0.78 (0.527–0.893)

Aberrant vocalizations

0.34 (–0.391 to 0.685)

ICC = Intraclass correlation, CI = confidence interval, NPI-C = Neuropsychiatric
Inventory-Clinician.

Table 4. Correlation coefficients between NPI-C domains, corresponding BEHAVE-AD
subscales, and overall BEHAVE-AD.
NPI-C domains/BEHAVE-AD subscale
/BEHAVE-AD total

Pearson’s
correlation

NPI-C Delusions/Paranoid and delusional ideation
/BEHAVE-AD total

0.925**
0.841**

NPI-C Hallucinations/Hallucinations
/BEHAVE-AD total

0.899**
0.783**

NPI-C Agitation/Aggressiveness
/BEHAVE-AD total

0.524**
0.561**

NPI-C Dysphoria/Affective disturbance
/BEHAVE-AD total

0.782**
0.312**

NPI-C Anxiety/Anxieties and phobias
/BEHAVE-AD total

0.429**
0.202**

NPI-C Disinhibition/Activity disturbances (15th question)
/BEHAVE-AD total

0.382**
0.463**

NPI-C Irritability-lability/Activity disturbances (14th question)
/BEHAVE-AD total

0.195**
0.420**

NPI-C Aberrant motor behavior/Activity disturbances
/BEHAVE-AD total

0.762**
0.660**

Sleep disorders/Diurnal rhythm disorders
/BEHAVE-AD total

0.821**
0.476**

Aberrant vocalizations/Aggressiveness (16th question)
/BEHAVE-AD total

0.469**
0.631**

**P < 0.01.
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Table 5. Correlation coefficients between NPI-C domains and corresponding BEHAVE-AD subscales according to the GDS stages.

NPI-C Domains/BEHAVE-AD subscale

GDS
stage 4,
r

GDS
stage 5,
r

GDS
stages 6–7,
r

NPI-C Delusions/Paranoid, delusional ideation

–0.027

0.815**

0.881**

0.874**

0.834**

NPI-C Hallucinations/Hallucinations

0.950**

NPI-C Agitation/Aggressiveness

–0.224

0.465**

0.560**

NPI-C Dysphoria/Affective disturbance
NPI-C Anxiety/Anxieties and phobias

0.829**

0.806**

0.775**

0.699**

0.350*

0.181

NPI-C Disinhibition/Activity disturbances (15th question)

0

0.229

0.151

NPI-C Irritability-lability/Activity disturbances (14th question)

0.1

0.036

0.086

NPI-C Aberrant motor behavior/Activity disturbances

0.298*

0.603**

0.719**

NPI-C Sleep disorders/Diurnal rhythm disorders

0.784**

0.797**

0.850**

Aberrant vocalizations/Aggressiveness (16th question)

0.427**

0.309

0.452**

*P < 0.05, **P < 0.01

3.6. Divergent validity
3.6.1. Correlation analysis of NPI-C with MMSE and
IADL
The correlations between NPI-C and MMSE were
significant for all domains except the dysphoria, anxiety,
and elation/euphoria domains. When we conducted the
correlation analysis of NPI-C with IADL, all domains were
statistically significantly correlated except aggression,
anxiety, elation/euphoria, and dysphoria.
3.6.2. Correlation Analysis of NPI-C with DAD
The correlations between most of the NPI-C domains
and the entire DAD were significant, although Pearson’s
coefficients were between 0.65 and 0.20. Additionally, the
dysphoria and sleep disorders domains of the NPI-C were
not significantly correlated with DAD.
4. Discussion
In this study, we analyzed the internal consistency
reliability, interrater reliability, and concurrent validity of
the Turkish version of the NPI-C.
The Turkish version of the NPI-C has good internal
consistency, with a Cronbach’s alpha of 0.75. The
interrater reliability was perfect for some domains, such
as disinhibition, apathy/indifference, and anxiety. Some
domains, such as aberrant vocalization and aberrant
motor behaviors, however, had low intraclass correlations
of between 0.31 and 0.34. In the study of the Brazilian
version of the NPI-C (24), the intraclass correlations were
between 0.947 and 0.812, which could be interpreted as
strong interrater reliability for all domains of the NPI-C.

The interrater reliability results, though, were generally
moderate to strong in the original NPI-C study and
the strongest intraclass correlations emerged in the
hallucinations and sleep disturbance domains.
For the validity of the Turkish version of the NPI-C,
delusions, hallucinations, and sleep disorders had the
highest correlation coefficients with the corresponding
subscales and items of BEHAVE-AD, at 0.925, 0.899, and
0.821 respectively. The weakest correlation was in the
irritability/lability domain (0.195) of the NPI-C. When
total convergent validity with BEHAVE-AD was analyzed,
the delusion domain again had the highest and anxiety
the lowest correlation coefficients (0.841 and 0.202). In
the original NPI-C study, the weakest correlation was
for apathy (r = 0.31) and the strongest was for dysphoria
domain (r = 0.61). In the Brazilian version, apathy had the
strongest correlation and hallucinations had the weakest,
which may be attributed to the scales used. In the Brazilian
study, BPSD, which is a scale developed for assessing
changes in the psychotic and depressive symptoms in
any kind of psychiatric disorder during pharmacological
treatment, had been used to assess hallucinations (27).
The strength of the correlation between NPI-C and
BEHAVE-AD changed at the different stages of GDS. The
correlations of disinhibition and irritability/lability were
not significant at any stage of GDS. In the Brazilian NPI-C
study, hallucinations and aberrant vocalizations were not
correlated with related scales at any severity stage (24);
however, in the Turkish version, hallucinations, dysphoria,
and sleep disorders domains were strongly correlated
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with the corresponding subscales of BEHAVE-AD. The
difference between the 2 studies may depend on the
different scales used for analyzing correlations.
The correlations between most of the NPI-C domains
and the total DAD scores were significant, although
Pearson’s coefficients were between 0.65 and 0.20.
Additionally, the dysphoria and sleep disorders domains
of the NPI-C were not significantly correlated with DAD.
There were some limitations to the study: the participants
were mostly younger, and most patients were diagnosed at
stage 4 (45.6%) or 5 (27.2%) of AD. Patients in the more
advanced stages were not as well represented. Furthermore,
interrater reliability for the aggression and elation/euphoria
domains could not be analyzed because patients included in
the study did show any symptoms of aggression or elation/
euphoria. Moreover, the potential to apply the results of

this study to all types of dementia or to patients in different
settings, such as nursing homes, is limited.
The NPI-C is advantageous because it includes detailed
questions and clinicians’ ratings. Clinician-caregiver
correlations for the NPI-C total severity ratings were
high (for example, 0.77), which indicates that clinical
judgement may be as reliable as caregivers’ ratings (25).
The revised, expanded, and clinician-rating version of the
NPI seems to be a sensitive measurement of the behavioral
and psychological symptoms of dementia. This study
shows that the Turkish-language version of the NPI-C is
a reliable and valid scale for patients diagnosed with AD.
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